Facebook Linkedin RSS Twitter Youtube
Home 2023

Bristol-Myers Squibb

EY Eyes Comeback for Biopharma M&A
GEN Edge

EY Eyes Comeback for Biopharma M&A

Double Dare: Exscientia Expands AI Platform into Antibody Design
Artificial Intelligence

Double Dare: Exscientia Expands AI Platform into Antibody Design

Biopharma Facility Planning Improves with Monte Carlo Simulation Modeling
Bioprocessing

Biopharma Facility Planning Improves with Monte Carlo Simulation Modeling

Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup
Cancer

Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup

Middlesex County, NJ: Where Life Sciences Companies Thrive
Industry News

Middlesex County, NJ: Where Life Sciences Companies Thrive

BMS, Immatics Launch Up-to-$4.2B Expanded Cancer Cell Therapy Collaboration
Cancer

BMS, Immatics Launch Up-to-$4.2B Expanded Cancer Cell Therapy Collaboration

Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring
Drug Discovery

Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring

Understanding How Production Processes Impact Drug Quality
Bioprocessing

Understanding How Production Processes Impact Drug Quality

Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis
Cancer

Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis

1234...28Page 3 of 28
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.